ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Cell Biology International
Volume 31, Issue 7, July 2007, Pages 711-715
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (431 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.cellbi.2007.01.003    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2007 International Federation for Cell Biology Published by Elsevier Ltd.

Induction of apoptosis in rat C6 glioma cells by panaxydol

Jian Haia, Corresponding Author Contact Information, 1, E-mail The Corresponding Author, Qi Linb, 1, Yang Lub, Hao Zhanga and Jing Yic

aDepartment of Neurosurgery, Tongji Hospital, Tongji University, 389 Xin-Cun Road, Shanghai 200065, China bDepartment of Pharmacy, Shanghai Jiao Tong University School of Medicine, Shanghai, China cDepartment of Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Received 6 July 2006; 
revised 15 December 2006; 
accepted 10 January 2007. 
Available online 14 January 2007.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Panaxydol is a naturally occurring non-peptidyl small molecule isolated from the lipophilic fractions of Panax notoginseng, a well-known Chinese traditional medicine. Previous studies have shown that panaxydol inhibited the growth of various kinds of malignant cell lines. To date, there has been no report concerning the effect of panaxydol on cell growth inhibition in glioma cells. In this paper, we examined panaxydol's antiproliferation and proapoptotic effects on rat C6 glioma cells and investigated its mechanism. Cell growth inhibition of panaxydol was determined by MTT reduction assay. Apoptosis of cells was measured by both Hoechst 33258 staining and Annexin V analysis. It was found that panaxydol markedly inhibited proliferation of C6 cells in a dose-dependent manner with ID50 of 40 μM. The cell apoptosis was observed at 48 h in the presence of panaxydol. In concert with these findings, Western blot analysis showed a decreased expression of bcl-2 and increased levels of Bax and caspase-3 in C6 cells treated by panaxydol. In conclusion, panaxydol has profound effects on growth and apoptosis of C6 cells, suggesting that panaxydol may be a potential candidate for the treatment of malignant gliomas.

Keywords: Apoptosis; C6 glioma cells; Panaxydol

Abbreviations: DMEM, Dulbecco modified Eagle medium; DMSO, dimethyl sulfoxide; FACS, fluorescence-activated cell sorter; MTT, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered saline; PI, propidium iodide; SEM, standard error of the mean

Article Outline

1. Introduction
2. Materials and methods
2.1. Panaxydol isolation and purification
2.2. Cell culture
2.3. Cell proliferation
2.4. Assessment of apoptosis
2.5. Western blot analysis
2.6. Statistical analysis
3. Results
3.1. Panaxydol inhibited proliferation in C6 glioma cells
3.2. Panaxydol Induced apoptosis in C6 cells
3.3. Apoptosis-related proteins in C6 glioma cells treated by panaxydol
4. Discussion
Acknowledgements
References




 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.